These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30777330)

  • 1. Self-assembled nanovehicle-mediated co-encapsulation of inactivated EV71 virus and CpG oligonucleotides elicits potent anti-EV71 humoral and cellular immune protective responses.
    Liang H; Xiao X; Zhang X; Hu Q; Yang Y; Cen S; Deng X; Sheng W
    Biochem Biophys Res Commun; 2019 Apr; 511(2):253-259. PubMed ID: 30777330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice.
    Pathinayake PS; Gayan Chathuranga WA; Lee HC; Chowdhury MYE; Sung MH; Lee JS; Kim CJ
    Arch Virol; 2018 Aug; 163(8):2073-2083. PubMed ID: 29619599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
    Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL
    Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge.
    Lin YL; Chow YH; Huang LM; Hsieh SM; Cheng PY; Hu KC; Chiang BL
    Sci Rep; 2018 Jul; 8(1):10713. PubMed ID: 30013088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    In HJ; Lim H; Lee JA; Lee SR; Jin YB; Jeong KJ; Hyeon JY; Yoo JS; Lee JW; Choi YK; Lee SW
    PLoS One; 2018; 13(10):e0202552. PubMed ID: 30278051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.
    Lin YL; Cheng PY; Chin CL; Huang LM; Lin SY; Chiang BL
    Vaccine; 2018 Jul; 36(29):4331-4338. PubMed ID: 29891349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
    Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
    Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys.
    Dong C; Liu L; Zhao H; Wang J; Liao Y; Zhang X; Na R; Liang Y; Wang L; Li Q
    Vaccine; 2011 Aug; 29(37):6269-75. PubMed ID: 21722686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.
    In HJ; Lim H; Lee JA; Kim HJ; Kim JW; Hyeon JY; Yeo SG; Lee JW; Yoo JS; Choi YK; Lee SW
    PLoS One; 2017; 12(5):e0178259. PubMed ID: 28542556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice.
    Mao Q; Dong C; Li X; Gao Q; Guo Z; Yao X; Wang Y; Gao F; Li F; Xu M; Yin W; Li Q; Shen X; Liang Z; Wang J
    PLoS One; 2012; 7(9):e46043. PubMed ID: 23029378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.
    Lin CW; Liu CC; Lu TC; Liu SJ; Chow YH; Chong P; Huang MH
    Biomed Res Int; 2014; 2014():670506. PubMed ID: 25006583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
    Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.
    Li HY; Han JF; Qin CF; Chen R
    Vaccine; 2013 Jul; 31(32):3281-7. PubMed ID: 23726823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
    Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and characterization of vaccine strain for Enterovirus 71 vaccine development.
    Chang JY; Chang CP; Tsai HH; Lee CD; Lian WC; Ih-Jen-Su ; Sai IH; Liu CC; Chou AH; Lu YJ; Chen CY; Lee PH; Chiang JR; Chong PC
    Vaccine; 2012 Jan; 30(4):703-11. PubMed ID: 22142585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
    Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
    Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children.
    Zhang Y; Wang L; Liao Y; Liu L; Ma K; Yang E; Wang J; Che Y; Jiang L; Pu J; Guo L; Feng M; Liang Y; Cui W; Yang H; Li Q
    Vaccine; 2015 Nov; 33(46):6290-7. PubMed ID: 26419198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
    Wang KT; Lin SJ; Wang HC; Chen PC; Lin JJ; Chiang JR; Chang CL; Shih DY; Lo CF; Wang DY
    Biologicals; 2016 Jul; 44(4):183-190. PubMed ID: 27068365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints.
    Zhu W; Jin P; Li JX; Zhu FC; Liu P
    Expert Rev Vaccines; 2017 Sep; 16(9):945-949. PubMed ID: 28548626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.